-
1
-
-
0342632445
-
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group
-
Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
-
Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol, 1999;117:1329-45.
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 1329-1345
-
-
-
2
-
-
0035009086
-
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy
-
Vertepofin In Photodynamic Therapy Study Group
-
Vertepofin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol, 2001;131:541-60.
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 541-560
-
-
-
4
-
-
1842556553
-
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials-TAP and VIP report no. 3
-
Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, et al. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol, 2004;137:683-96.
-
(2004)
Am J Ophthalmol
, vol.137
, pp. 683-696
-
-
Arnold, J.J.1
Blinder, K.J.2
Bressler, N.M.3
Bressler, S.B.4
Burdan, A.5
Haynes, L.6
-
5
-
-
21044453724
-
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
-
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA, 2005;102:7227-32.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 7227-7232
-
-
Hageman, G.S.1
Anderson, D.H.2
Johnson, L.V.3
Hancox, L.S.4
Taiber, A.J.5
Hardisty, L.I.6
-
6
-
-
29644437763
-
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration
-
Augustin AJ, Schmidt-Erfurth U. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology, 2006;113:14-22.
-
(2006)
Ophthalmology
, vol.113
, pp. 14-22
-
-
Augustin, A.J.1
Schmidt-Erfurth, U.2
-
7
-
-
0037383719
-
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
-
Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol, 2003;87:462-8.
-
(2003)
Br J Ophthalmol
, vol.87
, pp. 462-468
-
-
Jonas, J.B.1
Kreissig, I.2
Hugger, P.3
Sauder, G.4
Panda-Jonas, S.5
Degenring, R.6
-
8
-
-
18844420246
-
Verteporfin therapy in combination with triamcinolone: Published studies investigating a potential synergistic effect
-
Kaiser PK. Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect. Curr Med Res Opin, 2005;21:705-13.
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 705-713
-
-
Kaiser, P.K.1
-
9
-
-
1542317855
-
Safety of an intravitreal injection of triamcinolone: Results from a randomized clinical trial
-
Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol, 2004;122:336-40.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 336-340
-
-
Gillies, M.C.1
Simpson, J.M.2
Billson, F.A.3
Luo, W.4
Penfold, P.5
Chua, W.6
-
10
-
-
10744233542
-
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
-
Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol, 2003;136:791-6.
-
(2003)
Am J Ophthalmol
, vol.136
, pp. 791-796
-
-
Moshfeghi, D.M.1
Kaiser, P.K.2
Scott, I.U.3
Sears, J.E.4
Benz, M.5
Sinesterra, J.P.6
-
11
-
-
24344487980
-
Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization
-
Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina, 2005;25:685-90.
-
(2005)
Retina
, vol.25
, pp. 685-690
-
-
Spaide, R.F.1
Sorenson, J.2
Maranan, L.3
-
12
-
-
1542407176
-
Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration
-
Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol, 2004;88:344-7.
-
(2004)
Br J Ophthalmol
, vol.88
, pp. 344-347
-
-
Rechtman, E.1
Danis, R.P.2
Pratt, L.M.3
Harris, A.4
-
13
-
-
0042029477
-
Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization
-
Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2003;110:1517-25.
-
(2003)
Ophthalmology
, vol.110
, pp. 1517-1525
-
-
Spaide, R.F.1
Sorenson, J.2
Maranan, L.3
-
14
-
-
33644639309
-
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: A comparative study
-
Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol, 2006;90:337-41.
-
(2006)
Br J Ophthalmol
, vol.90
, pp. 337-341
-
-
Chan, W.M.1
Lai, T.Y.2
Wong, A.L.3
Tong, J.P.4
Liu, D.T.5
Lam, D.S.6
-
15
-
-
0031739874
-
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
-
Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust NZJ Ophthalmol, 1998;26:277-81.
-
(1998)
Aust NZJ Ophthalmol
, vol.26
, pp. 277-281
-
-
Challa, J.K.1
Gillies, M.C.2
Penfold, P.L.3
Gyory, J.F.4
Hunyor, A.B.5
Billson, F.A.6
-
16
-
-
0033944912
-
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
-
Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina, 2000;20:244-50.
-
(2000)
Retina
, vol.20
, pp. 244-250
-
-
Danis, R.P.1
Ciulla, T.A.2
Pratt, L.M.3
Anliker, W.4
-
17
-
-
0842283900
-
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration
-
Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol, 2004;122:218-22.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 218-222
-
-
Jonas, J.B.1
Akkoyun, I.2
Budde, W.M.3
Kreissig, I.4
Degenring, R.F.5
-
18
-
-
77957258555
-
Intravitreal triamcinolone acetonide for AMD
-
Presented at the 23-26 October, New Orleans, LA, USA, accessed 11 March
-
Roth DB, Walsman S, Modi A, et al. Intravitreal triamcinolone acetonide for AMD. Presented at the Americain Academy of Ophthalmology and European Society of Ophthalmology 2004 Joint meeting; 23-26 October 2004: New Orleans, LA, USA. http://www.aao.org [accessed 11 March 2005]
-
(2004)
Americain Academy of Ophthalmology and European Society of Ophthalmology 2004 Joint meeting
-
-
Roth, D.B.1
Walsman, S.2
Modi, A.3
-
19
-
-
0025776268
-
Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study
-
Macular Photocoagulation Study Group
-
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol, 1991;109:1242-57.
-
(1991)
Arch Ophthalmol
, vol.109
, pp. 1242-1257
-
-
-
20
-
-
1842530300
-
Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration
-
Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol, 2004;122:453-9.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 453-459
-
-
Axer-Siegel, R.1
Ehrlich, R.2
Rosenblatt, I.3
Kramer, M.4
Priel, E.5
Yassur, Y.6
-
21
-
-
31944437168
-
Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone
-
Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol, 2006;141:396-8.
-
(2006)
Am J Ophthalmol
, vol.141
, pp. 396-398
-
-
Michels, S.1
Aue, A.2
Simader, C.3
Geitzenauer, W.4
Sacu, S.5
Schmidt-Erfurth, U.6
|